Jubilant Pharmova to raise Rs.800-Cr via bond issue

Jubilant Pharmova , the pharmaceutical arm of the Jubilant Bhartia Group, is raising INR 800-Cr in debt through its maiden bond issue in the local market. The transaction comprises a base issue of INR 400-Cr and an equivalent greenshoe option. The bonds are structured with a three-year tenure and carry an indicative pricing of approximately 8.50%. The company plans to use the proceeds from this bond issuance to fund capital expenditure requirements and support its future expansion plans.